nodes	percent_of_prediction	percent_of_DWPC	metapath
Sotalol—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.272	1	CbGbCtD
Sotalol—Isoprenaline—PIK3R1—type 2 diabetes mellitus	0.00409	0.267	CrCbGaD
Sotalol—Ibutilide—KCNJ11—type 2 diabetes mellitus	0.00322	0.21	CrCbGaD
Sotalol—Ibuprofen—THBD—type 2 diabetes mellitus	0.00264	0.172	CrCbGaD
Sotalol—Ibuprofen—PLAT—type 2 diabetes mellitus	0.00181	0.118	CrCbGaD
Sotalol—Isoprenaline—ADRB3—type 2 diabetes mellitus	0.00148	0.0965	CrCbGaD
Sotalol—Ibuprofen—BCL2—type 2 diabetes mellitus	0.00104	0.0678	CrCbGaD
Sotalol—Ibuprofen—PPARG—type 2 diabetes mellitus	0.000576	0.0376	CrCbGaD
Sotalol—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000441	0.000795	CcSEcCtD
Sotalol—Vomiting—Glipizide—type 2 diabetes mellitus	0.000441	0.000794	CcSEcCtD
Sotalol—Syncope—Metformin—type 2 diabetes mellitus	0.00044	0.000793	CcSEcCtD
Sotalol—Oedema—Valsartan—type 2 diabetes mellitus	0.00044	0.000793	CcSEcCtD
Sotalol—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000439	0.000791	CcSEcCtD
Sotalol—Infection—Valsartan—type 2 diabetes mellitus	0.000437	0.000788	CcSEcCtD
Sotalol—Rash—Glipizide—type 2 diabetes mellitus	0.000437	0.000787	CcSEcCtD
Sotalol—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000437	0.000787	CcSEcCtD
Sotalol—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000437	0.000787	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000436	0.000786	CcSEcCtD
Sotalol—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000436	0.000786	CcSEcCtD
Sotalol—Oedema—Orlistat—type 2 diabetes mellitus	0.000435	0.000784	CcSEcCtD
Sotalol—Headache—Glipizide—type 2 diabetes mellitus	0.000434	0.000782	CcSEcCtD
Sotalol—Palpitations—Metformin—type 2 diabetes mellitus	0.000434	0.000782	CcSEcCtD
Sotalol—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000433	0.000781	CcSEcCtD
Sotalol—Shock—Valsartan—type 2 diabetes mellitus	0.000433	0.00078	CcSEcCtD
Sotalol—Infection—Orlistat—type 2 diabetes mellitus	0.000432	0.000778	CcSEcCtD
Sotalol—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000432	0.000778	CcSEcCtD
Sotalol—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000431	0.000776	CcSEcCtD
Sotalol—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.00043	0.000775	CcSEcCtD
Sotalol—Flatulence—Losartan—type 2 diabetes mellitus	0.00043	0.000774	CcSEcCtD
Sotalol—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000428	0.000771	CcSEcCtD
Sotalol—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000427	0.00077	CcSEcCtD
Sotalol—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000427	0.000769	CcSEcCtD
Sotalol—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000426	0.000768	CcSEcCtD
Sotalol—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000426	0.000767	CcSEcCtD
Sotalol—Hypertension—Metformin—type 2 diabetes mellitus	0.000424	0.000764	CcSEcCtD
Sotalol—Back pain—Losartan—type 2 diabetes mellitus	0.000422	0.00076	CcSEcCtD
Sotalol—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000422	0.00076	CcSEcCtD
Sotalol—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000422	0.00076	CcSEcCtD
Sotalol—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.00042	0.000757	CcSEcCtD
Sotalol—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000419	0.000755	CcSEcCtD
Sotalol—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000419	0.000754	CcSEcCtD
Sotalol—Chest pain—Metformin—type 2 diabetes mellitus	0.000418	0.000753	CcSEcCtD
Sotalol—Myalgia—Metformin—type 2 diabetes mellitus	0.000418	0.000753	CcSEcCtD
Sotalol—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000416	0.00075	CcSEcCtD
Sotalol—Headache—Pioglitazone—type 2 diabetes mellitus	0.000416	0.00075	CcSEcCtD
Sotalol—Syncope—Irbesartan—type 2 diabetes mellitus	0.000416	0.000749	CcSEcCtD
Sotalol—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000415	0.000747	CcSEcCtD
Sotalol—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000414	0.000746	CcSEcCtD
Sotalol—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000413	0.000744	CcSEcCtD
Sotalol—Nausea—Glipizide—type 2 diabetes mellitus	0.000412	0.000742	CcSEcCtD
Sotalol—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000411	0.000741	CcSEcCtD
Sotalol—Hypotension—Valsartan—type 2 diabetes mellitus	0.000411	0.000741	CcSEcCtD
Sotalol—Vision blurred—Losartan—type 2 diabetes mellitus	0.000411	0.000741	CcSEcCtD
Sotalol—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00041	0.000739	CcSEcCtD
Sotalol—Pain—Gliclazide—type 2 diabetes mellitus	0.00041	0.000738	CcSEcCtD
Sotalol—Rash—Glimepiride—type 2 diabetes mellitus	0.000408	0.000735	CcSEcCtD
Sotalol—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000407	0.000734	CcSEcCtD
Sotalol—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000407	0.000734	CcSEcCtD
Sotalol—Rash—Sitagliptin—type 2 diabetes mellitus	0.000407	0.000733	CcSEcCtD
Sotalol—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000406	0.000732	CcSEcCtD
Sotalol—Headache—Glimepiride—type 2 diabetes mellitus	0.000405	0.00073	CcSEcCtD
Sotalol—Cough—Irbesartan—type 2 diabetes mellitus	0.000404	0.000729	CcSEcCtD
Sotalol—Headache—Sitagliptin—type 2 diabetes mellitus	0.000404	0.000728	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000401	0.000722	CcSEcCtD
Sotalol—Oedema—Metformin—type 2 diabetes mellitus	0.000401	0.000722	CcSEcCtD
Sotalol—Hypertension—Irbesartan—type 2 diabetes mellitus	0.0004	0.000721	CcSEcCtD
Sotalol—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000399	0.000719	CcSEcCtD
Sotalol—Infection—Metformin—type 2 diabetes mellitus	0.000398	0.000717	CcSEcCtD
Sotalol—Insomnia—Valsartan—type 2 diabetes mellitus	0.000398	0.000717	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000396	0.000714	CcSEcCtD
Sotalol—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000395	0.000712	CcSEcCtD
Sotalol—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000395	0.000711	CcSEcCtD
Sotalol—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000395	0.000711	CcSEcCtD
Sotalol—Shock—Metformin—type 2 diabetes mellitus	0.000394	0.00071	CcSEcCtD
Sotalol—Insomnia—Orlistat—type 2 diabetes mellitus	0.000393	0.000709	CcSEcCtD
Sotalol—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000393	0.000708	CcSEcCtD
Sotalol—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000392	0.000707	CcSEcCtD
Sotalol—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000392	0.000707	CcSEcCtD
Sotalol—Vertigo—Losartan—type 2 diabetes mellitus	0.000392	0.000706	CcSEcCtD
Sotalol—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000392	0.000706	CcSEcCtD
Sotalol—Somnolence—Valsartan—type 2 diabetes mellitus	0.000391	0.000705	CcSEcCtD
Sotalol—Syncope—Losartan—type 2 diabetes mellitus	0.000391	0.000705	CcSEcCtD
Sotalol—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.00039	0.000704	CcSEcCtD
Sotalol—Leukopenia—Losartan—type 2 diabetes mellitus	0.00039	0.000703	CcSEcCtD
Sotalol—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000387	0.000698	CcSEcCtD
Sotalol—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000387	0.000698	CcSEcCtD
Sotalol—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000386	0.000695	CcSEcCtD
Sotalol—Palpitations—Losartan—type 2 diabetes mellitus	0.000385	0.000694	CcSEcCtD
Sotalol—Nausea—Glimepiride—type 2 diabetes mellitus	0.000384	0.000692	CcSEcCtD
Sotalol—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000384	0.000691	CcSEcCtD
Sotalol—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000383	0.000691	CcSEcCtD
Sotalol—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000383	0.00069	CcSEcCtD
Sotalol—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000383	0.00069	CcSEcCtD
Sotalol—Asthenia—Glyburide—type 2 diabetes mellitus	0.000383	0.00069	CcSEcCtD
Sotalol—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000383	0.000689	CcSEcCtD
Sotalol—Cough—Losartan—type 2 diabetes mellitus	0.000381	0.000686	CcSEcCtD
Sotalol—Alopecia—Ramipril—type 2 diabetes mellitus	0.00038	0.000684	CcSEcCtD
Sotalol—Fatigue—Valsartan—type 2 diabetes mellitus	0.000379	0.000684	CcSEcCtD
Sotalol—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000379	0.000682	CcSEcCtD
Sotalol—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000379	0.000682	CcSEcCtD
Sotalol—Oedema—Irbesartan—type 2 diabetes mellitus	0.000378	0.000681	CcSEcCtD
Sotalol—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000378	0.000681	CcSEcCtD
Sotalol—Pruritus—Glyburide—type 2 diabetes mellitus	0.000377	0.00068	CcSEcCtD
Sotalol—Infection—Irbesartan—type 2 diabetes mellitus	0.000376	0.000677	CcSEcCtD
Sotalol—Fatigue—Orlistat—type 2 diabetes mellitus	0.000375	0.000676	CcSEcCtD
Sotalol—Hypotension—Metformin—type 2 diabetes mellitus	0.000374	0.000675	CcSEcCtD
Sotalol—Shock—Irbesartan—type 2 diabetes mellitus	0.000372	0.00067	CcSEcCtD
Sotalol—Pain—Orlistat—type 2 diabetes mellitus	0.000372	0.00067	CcSEcCtD
Sotalol—Chest pain—Losartan—type 2 diabetes mellitus	0.000371	0.000669	CcSEcCtD
Sotalol—Myalgia—Losartan—type 2 diabetes mellitus	0.000371	0.000669	CcSEcCtD
Sotalol—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000371	0.000669	CcSEcCtD
Sotalol—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.00037	0.000667	CcSEcCtD
Sotalol—Anxiety—Losartan—type 2 diabetes mellitus	0.00037	0.000667	CcSEcCtD
Sotalol—Rash—Bromocriptine—type 2 diabetes mellitus	0.000368	0.000663	CcSEcCtD
Sotalol—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000368	0.000662	CcSEcCtD
Sotalol—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000366	0.00066	CcSEcCtD
Sotalol—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000366	0.000659	CcSEcCtD
Sotalol—Headache—Bromocriptine—type 2 diabetes mellitus	0.000366	0.000659	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000365	0.000658	CcSEcCtD
Sotalol—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000365	0.000658	CcSEcCtD
Sotalol—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.00036	0.000648	CcSEcCtD
Sotalol—Paraesthesia—Metformin—type 2 diabetes mellitus	0.00036	0.000648	CcSEcCtD
Sotalol—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.00036	0.000648	CcSEcCtD
Sotalol—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000357	0.000644	CcSEcCtD
Sotalol—Somnolence—Metformin—type 2 diabetes mellitus	0.000356	0.000642	CcSEcCtD
Sotalol—Oedema—Losartan—type 2 diabetes mellitus	0.000356	0.000641	CcSEcCtD
Sotalol—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000356	0.000641	CcSEcCtD
Sotalol—Infection—Losartan—type 2 diabetes mellitus	0.000354	0.000637	CcSEcCtD
Sotalol—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000353	0.000637	CcSEcCtD
Sotalol—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000353	0.000636	CcSEcCtD
Sotalol—Shock—Losartan—type 2 diabetes mellitus	0.00035	0.000631	CcSEcCtD
Sotalol—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000349	0.000628	CcSEcCtD
Sotalol—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000348	0.000628	CcSEcCtD
Sotalol—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000348	0.000627	CcSEcCtD
Sotalol—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000347	0.000625	CcSEcCtD
Sotalol—Fatigue—Metformin—type 2 diabetes mellitus	0.000346	0.000623	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000345	0.000621	CcSEcCtD
Sotalol—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000344	0.00062	CcSEcCtD
Sotalol—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000344	0.000619	CcSEcCtD
Sotalol—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000344	0.000619	CcSEcCtD
Sotalol—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000344	0.000619	CcSEcCtD
Sotalol—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.00034	0.000612	CcSEcCtD
Sotalol—Vomiting—Glyburide—type 2 diabetes mellitus	0.000339	0.000611	CcSEcCtD
Sotalol—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000339	0.000611	CcSEcCtD
Sotalol—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000337	0.000608	CcSEcCtD
Sotalol—Rash—Glyburide—type 2 diabetes mellitus	0.000336	0.000606	CcSEcCtD
Sotalol—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000336	0.000606	CcSEcCtD
Sotalol—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000336	0.000605	CcSEcCtD
Sotalol—Vertigo—Ramipril—type 2 diabetes mellitus	0.000336	0.000605	CcSEcCtD
Sotalol—Syncope—Ramipril—type 2 diabetes mellitus	0.000335	0.000604	CcSEcCtD
Sotalol—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000335	0.000603	CcSEcCtD
Sotalol—Headache—Glyburide—type 2 diabetes mellitus	0.000334	0.000602	CcSEcCtD
Sotalol—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000333	0.0006	CcSEcCtD
Sotalol—Hypotension—Losartan—type 2 diabetes mellitus	0.000333	0.000599	CcSEcCtD
Sotalol—Palpitations—Ramipril—type 2 diabetes mellitus	0.00033	0.000595	CcSEcCtD
Sotalol—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000329	0.000592	CcSEcCtD
Sotalol—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000329	0.000592	CcSEcCtD
Sotalol—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000328	0.000591	CcSEcCtD
Sotalol—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000328	0.00059	CcSEcCtD
Sotalol—Cough—Ramipril—type 2 diabetes mellitus	0.000326	0.000588	CcSEcCtD
Sotalol—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000326	0.000588	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000324	0.000584	CcSEcCtD
Sotalol—Pain—Irbesartan—type 2 diabetes mellitus	0.000323	0.000583	CcSEcCtD
Sotalol—Insomnia—Losartan—type 2 diabetes mellitus	0.000322	0.00058	CcSEcCtD
Sotalol—Paraesthesia—Losartan—type 2 diabetes mellitus	0.00032	0.000576	CcSEcCtD
Sotalol—Chest pain—Ramipril—type 2 diabetes mellitus	0.000318	0.000574	CcSEcCtD
Sotalol—Myalgia—Ramipril—type 2 diabetes mellitus	0.000318	0.000574	CcSEcCtD
Sotalol—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000317	0.000572	CcSEcCtD
Sotalol—Anxiety—Ramipril—type 2 diabetes mellitus	0.000317	0.000572	CcSEcCtD
Sotalol—Nausea—Glyburide—type 2 diabetes mellitus	0.000317	0.000571	CcSEcCtD
Sotalol—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000317	0.000571	CcSEcCtD
Sotalol—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000317	0.000571	CcSEcCtD
Sotalol—Somnolence—Losartan—type 2 diabetes mellitus	0.000316	0.00057	CcSEcCtD
Sotalol—Asthenia—Valsartan—type 2 diabetes mellitus	0.000316	0.000569	CcSEcCtD
Sotalol—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000313	0.000565	CcSEcCtD
Sotalol—Asthenia—Orlistat—type 2 diabetes mellitus	0.000312	0.000562	CcSEcCtD
Sotalol—Pruritus—Valsartan—type 2 diabetes mellitus	0.000311	0.000561	CcSEcCtD
Sotalol—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000309	0.000557	CcSEcCtD
Sotalol—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000309	0.000557	CcSEcCtD
Sotalol—Pruritus—Orlistat—type 2 diabetes mellitus	0.000308	0.000554	CcSEcCtD
Sotalol—Fatigue—Losartan—type 2 diabetes mellitus	0.000307	0.000553	CcSEcCtD
Sotalol—Oedema—Ramipril—type 2 diabetes mellitus	0.000305	0.00055	CcSEcCtD
Sotalol—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000305	0.000549	CcSEcCtD
Sotalol—Pain—Losartan—type 2 diabetes mellitus	0.000304	0.000548	CcSEcCtD
Sotalol—Rash—Gliclazide—type 2 diabetes mellitus	0.000302	0.000544	CcSEcCtD
Sotalol—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000302	0.000544	CcSEcCtD
Sotalol—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000301	0.000543	CcSEcCtD
Sotalol—Shock—Ramipril—type 2 diabetes mellitus	0.0003	0.000541	CcSEcCtD
Sotalol—Headache—Gliclazide—type 2 diabetes mellitus	0.0003	0.000541	CcSEcCtD
Sotalol—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000299	0.000539	CcSEcCtD
Sotalol—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000299	0.000539	CcSEcCtD
Sotalol—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000299	0.000538	CcSEcCtD
Sotalol—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000298	0.000536	CcSEcCtD
Sotalol—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000295	0.000532	CcSEcCtD
Sotalol—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000291	0.000524	CcSEcCtD
Sotalol—Dizziness—Valsartan—type 2 diabetes mellitus	0.000291	0.000524	CcSEcCtD
Sotalol—Dizziness—Orlistat—type 2 diabetes mellitus	0.000288	0.000518	CcSEcCtD
Sotalol—Asthenia—Metformin—type 2 diabetes mellitus	0.000288	0.000518	CcSEcCtD
Sotalol—Hypotension—Ramipril—type 2 diabetes mellitus	0.000285	0.000514	CcSEcCtD
Sotalol—Nausea—Gliclazide—type 2 diabetes mellitus	0.000285	0.000513	CcSEcCtD
Sotalol—Pruritus—Metformin—type 2 diabetes mellitus	0.000284	0.000511	CcSEcCtD
Sotalol—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000281	0.000507	CcSEcCtD
Sotalol—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000281	0.000507	CcSEcCtD
Sotalol—Vomiting—Valsartan—type 2 diabetes mellitus	0.00028	0.000504	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000278	0.000501	CcSEcCtD
Sotalol—Rash—Valsartan—type 2 diabetes mellitus	0.000277	0.0005	CcSEcCtD
Sotalol—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000277	0.0005	CcSEcCtD
Sotalol—Vomiting—Orlistat—type 2 diabetes mellitus	0.000277	0.000498	CcSEcCtD
Sotalol—Insomnia—Ramipril—type 2 diabetes mellitus	0.000276	0.000497	CcSEcCtD
Sotalol—Headache—Valsartan—type 2 diabetes mellitus	0.000276	0.000497	CcSEcCtD
Sotalol—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000274	0.000494	CcSEcCtD
Sotalol—Rash—Orlistat—type 2 diabetes mellitus	0.000274	0.000494	CcSEcCtD
Sotalol—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000274	0.000494	CcSEcCtD
Sotalol—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000274	0.000494	CcSEcCtD
Sotalol—Headache—Orlistat—type 2 diabetes mellitus	0.000272	0.000491	CcSEcCtD
Sotalol—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000272	0.00049	CcSEcCtD
Sotalol—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000271	0.000489	CcSEcCtD
Sotalol—Somnolence—Ramipril—type 2 diabetes mellitus	0.000271	0.000489	CcSEcCtD
Sotalol—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000269	0.000484	CcSEcCtD
Sotalol—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000268	0.000482	CcSEcCtD
Sotalol—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000265	0.000478	CcSEcCtD
Sotalol—Dizziness—Metformin—type 2 diabetes mellitus	0.000265	0.000478	CcSEcCtD
Sotalol—Fatigue—Ramipril—type 2 diabetes mellitus	0.000263	0.000474	CcSEcCtD
Sotalol—Nausea—Valsartan—type 2 diabetes mellitus	0.000261	0.000471	CcSEcCtD
Sotalol—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000259	0.000466	CcSEcCtD
Sotalol—Nausea—Orlistat—type 2 diabetes mellitus	0.000258	0.000465	CcSEcCtD
Sotalol—Asthenia—Losartan—type 2 diabetes mellitus	0.000255	0.00046	CcSEcCtD
Sotalol—Vomiting—Metformin—type 2 diabetes mellitus	0.000255	0.000459	CcSEcCtD
Sotalol—Rash—Metformin—type 2 diabetes mellitus	0.000253	0.000455	CcSEcCtD
Sotalol—Dermatitis—Metformin—type 2 diabetes mellitus	0.000252	0.000455	CcSEcCtD
Sotalol—Pruritus—Losartan—type 2 diabetes mellitus	0.000252	0.000454	CcSEcCtD
Sotalol—Headache—Metformin—type 2 diabetes mellitus	0.000251	0.000452	CcSEcCtD
Sotalol—Dizziness—Irbesartan—type 2 diabetes mellitus	0.00025	0.000451	CcSEcCtD
Sotalol—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.00025	0.00045	CcSEcCtD
Sotalol—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000244	0.000439	CcSEcCtD
Sotalol—Ibuprofen—PTGS2—type 2 diabetes mellitus	0.000243	0.0159	CrCbGaD
Sotalol—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000241	0.000435	CcSEcCtD
Sotalol—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000241	0.000435	CcSEcCtD
Sotalol—Vomiting—Irbesartan—type 2 diabetes mellitus	0.00024	0.000433	CcSEcCtD
Sotalol—Rash—Irbesartan—type 2 diabetes mellitus	0.000238	0.00043	CcSEcCtD
Sotalol—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000238	0.000429	CcSEcCtD
Sotalol—Nausea—Metformin—type 2 diabetes mellitus	0.000238	0.000429	CcSEcCtD
Sotalol—Headache—Irbesartan—type 2 diabetes mellitus	0.000237	0.000427	CcSEcCtD
Sotalol—Dizziness—Losartan—type 2 diabetes mellitus	0.000235	0.000424	CcSEcCtD
Sotalol—Vomiting—Losartan—type 2 diabetes mellitus	0.000226	0.000408	CcSEcCtD
Sotalol—Nausea—Irbesartan—type 2 diabetes mellitus	0.000225	0.000405	CcSEcCtD
Sotalol—Rash—Losartan—type 2 diabetes mellitus	0.000224	0.000404	CcSEcCtD
Sotalol—Dermatitis—Losartan—type 2 diabetes mellitus	0.000224	0.000404	CcSEcCtD
Sotalol—Headache—Losartan—type 2 diabetes mellitus	0.000223	0.000402	CcSEcCtD
Sotalol—Asthenia—Ramipril—type 2 diabetes mellitus	0.000219	0.000395	CcSEcCtD
Sotalol—Ibuprofen—ALB—type 2 diabetes mellitus	0.000217	0.0141	CrCbGaD
Sotalol—Pruritus—Ramipril—type 2 diabetes mellitus	0.000216	0.000389	CcSEcCtD
Sotalol—Nausea—Losartan—type 2 diabetes mellitus	0.000211	0.000381	CcSEcCtD
Sotalol—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000209	0.000376	CcSEcCtD
Sotalol—Dizziness—Ramipril—type 2 diabetes mellitus	0.000202	0.000364	CcSEcCtD
Sotalol—Vomiting—Ramipril—type 2 diabetes mellitus	0.000194	0.00035	CcSEcCtD
Sotalol—Rash—Ramipril—type 2 diabetes mellitus	0.000192	0.000347	CcSEcCtD
Sotalol—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000192	0.000346	CcSEcCtD
Sotalol—Headache—Ramipril—type 2 diabetes mellitus	0.000191	0.000344	CcSEcCtD
Sotalol—Nausea—Ramipril—type 2 diabetes mellitus	0.000181	0.000327	CcSEcCtD
Sotalol—ADRB1—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	0.000101	0.000641	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—C3—type 2 diabetes mellitus	9.99e-05	0.000631	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	9.97e-05	0.00063	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	9.91e-05	0.000627	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GIPR—type 2 diabetes mellitus	9.81e-05	0.00062	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GRK5—type 2 diabetes mellitus	9.81e-05	0.00062	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	9.7e-05	0.000613	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—AGT—type 2 diabetes mellitus	9.7e-05	0.000613	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GIPR—type 2 diabetes mellitus	9.59e-05	0.000607	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GRK5—type 2 diabetes mellitus	9.59e-05	0.000607	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	9.49e-05	0.0006	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—AGT—type 2 diabetes mellitus	9.49e-05	0.0006	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—IAPP—type 2 diabetes mellitus	9.48e-05	0.000599	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	9.42e-05	0.000595	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—IAPP—type 2 diabetes mellitus	9.27e-05	0.000586	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	9.25e-05	0.000585	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	9.21e-05	0.000583	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	9.2e-05	0.000582	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	9.16e-05	0.000579	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	9.05e-05	0.000572	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	9e-05	0.000569	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MC4R—type 2 diabetes mellitus	8.97e-05	0.000567	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	8.96e-05	0.000567	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	8.96e-05	0.000567	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	8.93e-05	0.000565	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	8.82e-05	0.000558	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	8.81e-05	0.000557	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MC4R—type 2 diabetes mellitus	8.77e-05	0.000555	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	8.77e-05	0.000555	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	8.73e-05	0.000552	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GIP—type 2 diabetes mellitus	8.63e-05	0.000546	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	8.63e-05	0.000545	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	8.62e-05	0.000545	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	8.55e-05	0.000541	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GIP—type 2 diabetes mellitus	8.45e-05	0.000534	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	8.37e-05	0.000529	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	8.32e-05	0.000526	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—LEPR—type 2 diabetes mellitus	8.2e-05	0.000519	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—GCG—type 2 diabetes mellitus	8.16e-05	0.000516	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	8.14e-05	0.000515	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	8.14e-05	0.000515	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—GHRL—type 2 diabetes mellitus	8.11e-05	0.000513	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	8.03e-05	0.000508	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—LEPR—type 2 diabetes mellitus	8.02e-05	0.000507	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CALCA—type 2 diabetes mellitus	8.01e-05	0.000506	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—CCL2—type 2 diabetes mellitus	7.99e-05	0.000505	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—GCG—type 2 diabetes mellitus	7.99e-05	0.000505	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	7.96e-05	0.000504	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—GHRL—type 2 diabetes mellitus	7.93e-05	0.000501	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	7.86e-05	0.000497	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	7.84e-05	0.000496	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CALCA—type 2 diabetes mellitus	7.83e-05	0.000495	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—CCL2—type 2 diabetes mellitus	7.81e-05	0.000494	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	7.67e-05	0.000485	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TLE4—type 2 diabetes mellitus	7.63e-05	0.000482	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TLE4—type 2 diabetes mellitus	7.46e-05	0.000472	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—GCG—type 2 diabetes mellitus	7.41e-05	0.000469	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	7.34e-05	0.000464	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	7.29e-05	0.000461	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—GCG—type 2 diabetes mellitus	7.25e-05	0.000459	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ADRB3—type 2 diabetes mellitus	7.18e-05	0.000454	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	7.14e-05	0.000451	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	7.09e-05	0.000448	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	7.04e-05	0.000445	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	6.94e-05	0.000439	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CRHR1—type 2 diabetes mellitus	6.94e-05	0.000439	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	6.88e-05	0.000435	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—AVP—type 2 diabetes mellitus	6.79e-05	0.000429	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	6.6e-05	0.000418	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	6.54e-05	0.000414	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	6.48e-05	0.00041	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	6.48e-05	0.00041	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	6.46e-05	0.000408	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	6.4e-05	0.000405	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	6.39e-05	0.000404	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SPRY2—type 2 diabetes mellitus	6.34e-05	0.000401	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	6.34e-05	0.000401	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—RBP4—type 2 diabetes mellitus	6.32e-05	0.0004	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	6.32e-05	0.0004	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—AVP—type 2 diabetes mellitus	6.3e-05	0.000399	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	6.3e-05	0.000399	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	6.27e-05	0.000397	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—GNB3—type 2 diabetes mellitus	6.25e-05	0.000395	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	6.22e-05	0.000393	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GLP1R—type 2 diabetes mellitus	6.18e-05	0.000391	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—RBP4—type 2 diabetes mellitus	6.18e-05	0.000391	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—AVP—type 2 diabetes mellitus	6.17e-05	0.00039	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—MMP3—type 2 diabetes mellitus	6.17e-05	0.00039	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	6.14e-05	0.000388	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CCKAR—type 2 diabetes mellitus	6.08e-05	0.000385	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	6e-05	0.000379	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	5.9e-05	0.000373	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—EDN1—type 2 diabetes mellitus	5.87e-05	0.000371	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	5.77e-05	0.000365	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—C3—type 2 diabetes mellitus	5.77e-05	0.000365	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	5.7e-05	0.00036	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—C3—type 2 diabetes mellitus	5.64e-05	0.000357	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	5.63e-05	0.000356	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IAPP—type 2 diabetes mellitus	5.6e-05	0.000354	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	5.57e-05	0.000352	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—INSR—type 2 diabetes mellitus	5.56e-05	0.000352	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	5.51e-05	0.000348	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	5.48e-05	0.000347	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IAPP—type 2 diabetes mellitus	5.48e-05	0.000346	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	5.47e-05	0.000346	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	5.46e-05	0.000345	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—INSR—type 2 diabetes mellitus	5.44e-05	0.000344	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	5.43e-05	0.000344	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	5.36e-05	0.000339	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	5.36e-05	0.000339	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	5.35e-05	0.000338	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	5.34e-05	0.000338	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	5.32e-05	0.000336	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	5.24e-05	0.000332	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—C3—type 2 diabetes mellitus	5.24e-05	0.000331	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	5.2e-05	0.000329	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—C3—type 2 diabetes mellitus	5.12e-05	0.000324	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	5.09e-05	0.000322	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	5.06e-05	0.00032	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	5.05e-05	0.000319	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	5.05e-05	0.000319	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—AGT—type 2 diabetes mellitus	4.98e-05	0.000315	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	4.95e-05	0.000313	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	4.94e-05	0.000312	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	4.94e-05	0.000312	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	4.91e-05	0.000311	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	4.89e-05	0.000309	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CYBA—type 2 diabetes mellitus	4.89e-05	0.000309	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—AGT—type 2 diabetes mellitus	4.87e-05	0.000308	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	4.81e-05	0.000304	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	4.81e-05	0.000304	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PLAT—type 2 diabetes mellitus	4.79e-05	0.000303	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GHRL—type 2 diabetes mellitus	4.79e-05	0.000303	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	4.79e-05	0.000303	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CYBA—type 2 diabetes mellitus	4.79e-05	0.000303	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CALCA—type 2 diabetes mellitus	4.73e-05	0.000299	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	4.7e-05	0.000297	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GHRL—type 2 diabetes mellitus	4.68e-05	0.000296	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PLAT—type 2 diabetes mellitus	4.68e-05	0.000296	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CALCA—type 2 diabetes mellitus	4.63e-05	0.000293	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	4.6e-05	0.000291	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	4.5e-05	0.000284	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	4.46e-05	0.000282	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	4.43e-05	0.00028	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GCG—type 2 diabetes mellitus	4.38e-05	0.000277	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	4.38e-05	0.000277	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	4.36e-05	0.000276	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	4.34e-05	0.000274	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	4.31e-05	0.000272	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	4.3e-05	0.000272	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GCG—type 2 diabetes mellitus	4.28e-05	0.000271	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	4.28e-05	0.000271	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	4.22e-05	0.000267	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	4.2e-05	0.000266	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	4.1e-05	0.000259	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	4.03e-05	0.000255	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	4.02e-05	0.000254	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	4.01e-05	0.000254	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	3.94e-05	0.000249	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	3.94e-05	0.000249	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	3.81e-05	0.000241	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GNB3—type 2 diabetes mellitus	3.78e-05	0.000239	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	3.73e-05	0.000236	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—AVP—type 2 diabetes mellitus	3.72e-05	0.000236	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.72e-05	0.000236	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.71e-05	0.000234	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GNB3—type 2 diabetes mellitus	3.69e-05	0.000234	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.69e-05	0.000233	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	3.65e-05	0.000231	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.64e-05	0.00023	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—AVP—type 2 diabetes mellitus	3.64e-05	0.00023	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.63e-05	0.000229	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.61e-05	0.000228	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—APOB—type 2 diabetes mellitus	3.6e-05	0.000228	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.58e-05	0.000227	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	3.57e-05	0.000226	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.54e-05	0.000224	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—APOB—type 2 diabetes mellitus	3.52e-05	0.000223	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.51e-05	0.000222	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.47e-05	0.000219	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—LPL—type 2 diabetes mellitus	3.44e-05	0.000217	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.36e-05	0.000213	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—LPL—type 2 diabetes mellitus	3.36e-05	0.000213	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.29e-05	0.000208	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.22e-05	0.000204	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.17e-05	0.0002	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.15e-05	0.000199	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.1e-05	0.000196	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—C3—type 2 diabetes mellitus	3.09e-05	0.000196	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—C3—type 2 diabetes mellitus	3.03e-05	0.000191	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.95e-05	0.000187	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.94e-05	0.000186	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—AGT—type 2 diabetes mellitus	2.94e-05	0.000186	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.89e-05	0.000183	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.89e-05	0.000183	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—LEP—type 2 diabetes mellitus	2.88e-05	0.000182	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—APOE—type 2 diabetes mellitus	2.88e-05	0.000182	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.88e-05	0.000182	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—AGT—type 2 diabetes mellitus	2.88e-05	0.000182	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.85e-05	0.00018	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.83e-05	0.000179	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—LEP—type 2 diabetes mellitus	2.82e-05	0.000178	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—APOE—type 2 diabetes mellitus	2.82e-05	0.000178	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.79e-05	0.000176	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.72e-05	0.000172	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.66e-05	0.000168	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.57e-05	0.000163	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.51e-05	0.000159	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—INS—type 2 diabetes mellitus	2.46e-05	0.000156	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.42e-05	0.000153	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—INS—type 2 diabetes mellitus	2.41e-05	0.000152	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.38e-05	0.000151	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.38e-05	0.00015	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.37e-05	0.00015	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.37e-05	0.00015	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.33e-05	0.000147	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.33e-05	0.000147	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.32e-05	0.000147	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.26e-05	0.000143	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.21e-05	0.00014	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.16e-05	0.000136	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.16e-05	0.000136	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.11e-05	0.000134	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.11e-05	0.000134	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.03e-05	0.000128	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.99e-05	0.000126	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.85e-05	0.000117	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.83e-05	0.000116	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.82e-05	0.000115	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.81e-05	0.000114	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.79e-05	0.000113	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.78e-05	0.000113	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.73e-05	0.00011	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.71e-05	0.000108	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.69e-05	0.000107	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.68e-05	0.000106	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.68e-05	0.000106	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.64e-05	0.000104	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.6e-05	0.000101	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.56e-05	9.88e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.55e-05	9.83e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.52e-05	9.62e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.43e-05	9.03e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.4e-05	8.85e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.4e-05	8.83e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.37e-05	8.66e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.08e-05	6.8e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.05e-05	6.65e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.92e-06	6.27e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.71e-06	6.14e-05	CbGpPWpGaD
